5-Lipoxygenase contributes to PPARγ activation in macrophages in response to apoptotic cells

Cellular Signalling

Volumn 25, Issue 12, 2013, Pages 2762-2768

  Von Knethen, Andreas ^a   Sha, Lisa K ^a   Kuchler, Laura ^a   Heeg, Annika K ^a   Fuhrmann, Dominik ^a   Heide, Heinrich ^a   Wittig, Ilka ^a   Maier, Thorsten J ^a   Steinhilber, Dieter ^a   Brüne, Bernhard ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

5 Lipoxygenase; Alternative activation; Efferocytosis; Macrophages; Sepsis

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ZILEUTON; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CELL MEMBRANE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA CELL LINE; LIPID RAFT; MACROPHAGE ACTIVATION; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; SEPSIS; WILD TYPE; ANIMAL; CELL LINE; IMMUNOLOGY; JURKAT CELL LINE; MACROPHAGE; METABOLISM; MOUSE; PROTEIN TRANSPORT;

MURINAE;

ANIMALS; APOPTOSIS; ARACHIDONATE 5-LIPOXYGENASE; CELL LINE; HUMANS; JURKAT CELLS; MACROPHAGES; MEMBRANE MICRODOMAINS; MICE; PPAR GAMMA; PROTEIN TRANSPORT; REACTIVE OXYGEN SPECIES;

EID: 84884745108     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2013.08.045     Document Type: Article

References (47)

1. O'Brien J.M., Ali N.A., Aberegg S.K., Abraham E. Am. J. Med. 2007, 120:1012-1022.
2. Vincent J.L. Minerva Anestesiol. 2008, 74:293-296.
3. Vincent J.L., Sakr Y., Sprung C.L., Ranieri V.M., Reinhart K., Gerlach H., Moreno R., Carlet J., Le Gall J.R., Payen D. Crit. Care Med. 2006, 34:344-353.
4. Stearns-Kurosawa D.J., Osuchowski M.F., Valentine C., Kurosawa S., Remick D.G. Annu. Rev. Pathol. 2011, 6:19-48.
5. Rittirsch D., Flierl M.A., Ward P.A. Nat. Rev. Immunol. 2008, 8:776-787.
6. Nickel K.F., Renne T. Thromb. Res. 2012, 130(Suppl. 1):S78-S83.
7. van der Poll T., van Zoelen M.A., Wiersinga W.J. Contrib. Microbiol. 2011, 17:125-136.
8. Condotta S.A., Cabrera-Perez J., Badovinac V.P., Griffith T.S. Crit. Rev. Immunol. 2013, 33:23-40.
9. Salomao R., Brunialti M.K., Rapozo M.M., Baggio-Zappia G.L., Galanos C., Freudenberg M. Shock 2012, 38:227-242.
10. Korns D., Frasch S.C., Fernandez-Boyanapalli R., Henson P.M., Bratton D.L. Front. Immunol. 2011, 2:57.
11. Novak M.L., Koh T.J. J. Leukoc. Biol. 2013, 93:875-881.
12. Sica A., Mantovani A. J. Clin. Invest. 2012, 122:787-795.
13. Benoit M., Desnues B., Mege J.L. J. Immunol. 2008, 181:3733-3739.
14. Odegaard J.I., Ricardo-Gonzalez R.R., Goforth M.H., Morel C.R., Subramanian V., Mukundan L., Red Eagle A., Vats D., Brombacher F., Ferrante A.W., Chawla A. Nature 2007, 447:1116-1120.
15. Johann A.M., von Knethen A., Lindemann D., Brune B. Cell Death Differ. 2006, 13:1533-1540.
16. Kim K.B., Lee J.S., Ko Y.G. Methods Mol. Biol. 2008, 424:413-422.
17. Mege J.L., Mehraj V., Capo C. Curr. Opin. Infect. Dis. 2011, 24:230-234.
18. Hotchkiss R.S., Nicholson D.W. Nat. Rev. Immunol. 2006, 6:813-822.
19. Weigert A., Johann A.M., von Knethen A., Schmidt H., Geisslinger G., Brune B. Blood 2006, 108:1635-1642.
20. Tavano R., Gri G., Molon B., Marinari B., Rudd C.E., Tuosto L., Viola A. J. Immunol. 2004, 173:5392-5397.
21. Pizzo P., Giurisato E., Bigsten A., Tassi M., Tavano R., Shaw A., Viola A. Immunol. Lett. 2004, 91:3-9.
22. Fischer A.S., Metzner J., Steinbrink S.D., Ulrich S., Angioni C., Geisslinger G., Steinhilber D., Maier T.J. Br. J. Pharmacol. 2010, 161:936-949.
23. Brock T.G., Lee Y.J., Maydanski E., Marburger T.L., Luo M., Paine R., Peters-Golden M. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289:L224-L232.
24. Serhan C.N., Savill J. Nat. Immunol. 2005, 6:1191-1197.
25. Mantovani A., Biswas S.K., Galdiero M.R., Sica A., Locati M. J. Pathol. 2013, 229:176-185.
26. Opal S.M. Int. J. Antimicrob. Agents 2010, 36(Suppl. 2):S70-S73.
27. Bouhlel M.A., Staels B., Chinetti-Gbaguidi G. J. Intern. Med. 2008, 263:28-42.
28. Olefsky J.M., Glass C.K. Annu. Rev. Physiol. 2010, 72:219-246.
29. Gallardo-Soler A., Gomez-Nieto C., Campo M.L., Marathe C., Tontonoz P., Castrillo A., Corraliza I. Mol. Endocrinol. 2008, 22:1394-1402.
30. Segawa K., Suzuki J., Nagata S. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:19246-19251.
31. Gardai S.J., Bratton D.L., Ogden C.A., Henson P.M. J. Leukoc. Biol. 2006, 79:896-903.
32. George K.S., Wu S. Toxicol. Appl. Pharmacol. 2012, 259:311-319.
33. Devitt A., Marshall L.J. J. Leukoc. Biol. 2011, 90:447-457.
34. Czimmerer Z., Varga T., Poliska S., Nemet I., Szanto A., Nagy L. Immunobiology 2012, 217:1301-1314.
35. Grant G.E., Gravel S., Guay J., Patel P., Mazer B.D., Rokach J., Powell W.S. Free Radic. Biol. Med. 2011, 50:1297-1304.
36. Nagashima T., Ichimiya S., Kikuchi T., Saito Y., Matsumiya H., Ara S., Koshiba S., Zhang J., Hatate C., Tonooka A., Kubo T., Ye R.C., Hirose B., Shirasaki H., Izumi T., Takami T., Himi T., Sato N. Am. J. Pathol. 2011, 178:222-232.
37. Radmark O., Samuelsson B. J. Lipid Res. 2009, 50:S40-S45. (Suppl.).
38. Al-Saffar N.M., Titley J.C., Robertson D., Clarke P.A., Jackson L.E., Leach M.O., Ronen S.M. Br. J. Cancer 2002, 86:963-970.
39. Bozza P.T., Magalhaes K.G., Weller P.F. Biochim. Biophys. Acta 2009, 1791:540-551.
40. Hanaka H., Shimizu T., Izumi T. Biochem. Biophys. Res. Commun. 2005, 338:111-116.
41. Boyd R.S., Jukes-Jones R., Walewska R., Brown D., Dyer M.J., Cain K. Mol. Cell. Proteomics 2009, 8:1501-1515.
42. You H.J., Seo J.M., Moon J.Y., Han S.S., Ko Y.G., Kim J.H. Mol. Cells 2007, 23:57-63.
43. Sobrado M., Pereira M.P., Ballesteros I., Hurtado O., Fernandez-Lopez D., Pradillo J.M., Caso J.R., Vivancos J., Nombela F., Serena J., Lizasoain I., Moro M.A. J. Neurosci. 2009, 29:3875-3884.
44. Collin M., Rossi A., Cuzzocrea S., Patel N.S., Di Paola R., Hadley J., Collino M., Sautebin L., Thiemermann C. J. Leukoc. Biol. 2004, 76:961-970.
45. Benjamim C.F., Canetti C., Cunha F.Q., Kunkel S.L., Peters-Golden M. J. Immunol. 2005, 174:1616-1620.
46. Emerson M.R., LeVine S.M. Brain Res. 2004, 1021:140-145.
47. Poeckel D., Funk C.D. Cardiovasc. Res. 2010, 86:243-253.